Dimitra Rontogianni

2.2k total citations
88 papers, 1.4k citations indexed

About

Dimitra Rontogianni is a scholar working on Oncology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Dimitra Rontogianni has authored 88 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 32 papers in Pathology and Forensic Medicine and 24 papers in Surgery. Recurrent topics in Dimitra Rontogianni's work include Lymphoma Diagnosis and Treatment (26 papers), Viral-associated cancers and disorders (11 papers) and Chronic Lymphocytic Leukemia Research (9 papers). Dimitra Rontogianni is often cited by papers focused on Lymphoma Diagnosis and Treatment (26 papers), Viral-associated cancers and disorders (11 papers) and Chronic Lymphocytic Leukemia Research (9 papers). Dimitra Rontogianni collaborates with scholars based in Greece, United States and Germany. Dimitra Rontogianni's co-authors include Theofanis Economopoulos, Nikolaos I. Xiros, Amanda Psyrri, Dimitrios Pectasides, Sotirios G. Papageorgiou, Kalliopi Stefanaki, Panagiotis Kanavaros, George Fountzilas, Meletios Α. Dimopoulos and Ion Bellenis and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Dimitra Rontogianni

85 papers receiving 1.4k citations

Peers

Dimitra Rontogianni
King H. Lam Netherlands
Yasser Khafaga Saudi Arabia
M Koss United States
King H. Lam Netherlands
Dimitra Rontogianni
Citations per year, relative to Dimitra Rontogianni Dimitra Rontogianni (= 1×) peers King H. Lam

Countries citing papers authored by Dimitra Rontogianni

Since Specialization
Citations

This map shows the geographic impact of Dimitra Rontogianni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dimitra Rontogianni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dimitra Rontogianni more than expected).

Fields of papers citing papers by Dimitra Rontogianni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dimitra Rontogianni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dimitra Rontogianni. The network helps show where Dimitra Rontogianni may publish in the future.

Co-authorship network of co-authors of Dimitra Rontogianni

This figure shows the co-authorship network connecting the top 25 collaborators of Dimitra Rontogianni. A scholar is included among the top collaborators of Dimitra Rontogianni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dimitra Rontogianni. Dimitra Rontogianni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stergiou, Ioanna Ε., Georgia Levidou, Stavros P. Papadakos, et al.. (2024). PD-L1 Expression in Neoplastic and Immune Cells of Thymic Epithelial Tumors: Correlations with Disease Characteristics and HDAC Expression. Biomedicines. 12(4). 772–772. 3 indexed citations
3.
Levidou, Georgia, et al.. (2023). Histone Deacetylases (HDACs): Promising Biomarkers and Potential Therapeutic Targets in Thymic Epithelial Tumors. International Journal of Molecular Sciences. 24(5). 4263–4263. 6 indexed citations
4.
Masaoutis, Christos, Panagiotis Sarantis, Nikolaos Tsoukalas, et al.. (2021). Ephrin Receptors (Ephs) Expression in Thymic Epithelial Tumors: Prognostic Implications and Future Therapeutic Approaches. Diagnostics. 11(12). 2265–2265. 9 indexed citations
5.
Vakrakou, Aigli G., Maria‐Eleftheria Evangelopoulos, G. Fragoulis, et al.. (2021). IgG4-related autoimmune manifestations in Alemtuzumab-treated multiple sclerosis patients. Journal of Neuroimmunology. 361. 577759–577759. 4 indexed citations
6.
Papadopoulou, Kyriaki, Simon S. Murray, Kyriaki Manousou, et al.. (2017). Genotyping and mRNA profiling reveal actionable targets in biliary tract cancers. Annals of Oncology. 28. v246–v246. 1 indexed citations
7.
Sachanas, Sotirios, Gerassimos A. Pangalis, Maria Moschogiannis, et al.. (2017). Hodgkin Lymphoma Transformation of Chronic Lymphocytic Leukemia Under Ibrutinib Therapy: Chance Association or Therapy-related?. Anticancer Research. 37(6). 3277–3280. 5 indexed citations
9.
Semitekolou, Maria, Ioanna E. Galani, Ioannis Morianos, et al.. (2013). CXCL13 Production in B Cells via Toll-like Receptor/Lymphotoxin Receptor Signaling is Involved in Lymphoid Neogenesis in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 187(11). 1194–1202. 78 indexed citations
10.
Κalamatianos, Theodosis, George Stranjalis, Lampis C. Stavrinou, et al.. (2013). The Evangelismos hospital central nervous system tumor registry: Analysis of 1414 cases (1998-2009). Surgical Neurology International. 4(1). 23–23. 6 indexed citations
11.
Triantafillidou, Christina, Effrosyni D. Manali, Christina Μagkou, et al.. (2011). Medical Research Council dyspnea scale does not relate to fibroblast foci profusion in IPF. Diagnostic Pathology. 6(1). 28–28. 2 indexed citations
12.
Psyrri, Amanda, Sotirios G. Papageorgiou, Andreas Scorilas, et al.. (2009). Phosphatidylinositol 3′-Kinase Catalytic Subunit α Gene Amplification Contributes to the Pathogenesis of Mantle Cell Lymphoma. Clinical Cancer Research. 15(18). 5724–5732. 86 indexed citations
13.
Pavlakis, Kitty, Panteleimon Kountourakis, Efstathios N. Stathopoulos, et al.. (2007). Her-2 Protein Expression, Cellular Localization, and Gene Amplification in Colorectal Carcinoma. Applied immunohistochemistry & molecular morphology. 15(4). 441–445. 9 indexed citations
14.
Zisis, Charalambos, et al.. (2005). Teratoma occupying the left hemithorax. World Journal of Surgical Oncology. 3(1). 76–76. 27 indexed citations
15.
Economopoulos, T., Sotirios G. Papageorgiou, Meletios Α. Dimopoulos, et al.. (2005). Non-Hodgkin’s Lymphomas in Greece according to the WHO Classification of Lymphoid Neoplasms. Acta Haematologica. 113(2). 97–103. 26 indexed citations
16.
Zisis, Charalambos, et al.. (2005). Lymphangiomatous hamartoma: Cause or bystander of the isolated chylopericardium?. Journal of Thoracic and Cardiovascular Surgery. 130(4). 1201–1202. 5 indexed citations
17.
Bai, Maria, Elena Tsanou, Niki J. Agnantis, et al.. (2004). Proliferation profile of classical Hodgkin's lymphomas. Increased expression of the protein cyclin D2 in Hodgkin's and Reed–Sternberg cells. Modern Pathology. 17(11). 1338–1345. 23 indexed citations
18.
Tsagarakis, Stylianos, et al.. (2003). A Reappraisal of the Utility of Somatostatin Receptor Scintigraphy in Patients with Ectopic Adrenocorticotropin Cushing’s Syndrome. The Journal of Clinical Endocrinology & Metabolism. 88(10). 4754–4758. 59 indexed citations
19.
Tsirigotis, Panagiotis, et al.. (2003). 2-Deoxycoformycin in the treatment of T-large granular lymphocyte leukemia. Leukemia Research. 27(9). 865–867. 11 indexed citations
20.
Tsirigotis, Panagiotis, Theofanis Economopoulos, Dimitra Rontogianni, et al.. (2001). T-Cell-Rich B-Cell Lymphoma. Oncology. 61(4). 257–264. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026